World's
Most Adopted
Healthcare AI
AI For
Chest | Heart | Neuro | MSK | Mammo
In the Spotlight: Qure at RSNA 2023
Hear from Our Customers & Partners
At Blackford Booth
Qure.ai: Driving efficient workflows
Date: 26th Nov, Sunday | 3:45PM CST
Venue: Ignite AI Visionary Theater, #4747
Speaker:
Dr Samir Shah
Chief Medical Officer, Qure.ai
RSNA 2023 IAIP Demo Session
Inpatient vs Outpatient Lung Cancer Workup
Date: November 26 – 29
Venue: AI Showcase South Hall A, Level 3, Booth 4358
Key Opinion Leader Sessions at the Qure booth (#4573)
Speaker Session
AI-driven efficient ER reporting
MJ Negahdar, Ph.D., MBA
Assistant Professor, Department of Radiology, School of Medicine, University of Louisville
Speaker Session
AI driven lung cancer pathways
Nick Woznitza
Associate Prof, University College London (UK)
Speaker Session
AI in Neuro-Critical Workflows
Dr. Remy Lobo
Clinical Assistant Professor, Neuroradiology, University of Michigan (USA)
Dr. Alex Novak
RCEM Associate Professor of Emergency Medicine (UK)
Abstract/Poster presentation: RSNA Award winner
Title: Autonomous AI - based CXR interpretation for predicting Congestive Heart Failure: A multicenter study
Authors: Emiliano Garza, Mannudeep Kalra, Dennis Robert, Sai Kiran, Preetham Putha, Charu Arora, Manoj Tadepalli, Subba R Digamurthy, Bernardo Bizzo, Dr. Dreyer
Tuesday, Nov 28 12:45 PM - 1:15 PM CST
Know moreAbstract/Poster presentation
Title: Impact of an AI-based workflow in interpretation of chest radiographs.
Authors: Abhishek Patil, Dennis Robert, Charu Arora, Syed Pasha, Anshul Chauhan, Anagh Purkar, Anshul Kumar Singh, Saigopal Sathyamurthy, Preetham Putha, Aditya Daftary
Sunday, Nov 26 9:30 AM - 10:00 AM CST
Know moreAbstract/Poster presentation
Title: Automated Detection of Multiple Fracture from X-Rays Using Multitask Deep Neural Network
Authors: Huib Ruitenbeek, Sahil (Sahil), Ravi Kushwaha, Swetha Tanamala, Saigopal Sathyamurthy, Subhankar Chattoraj, J. Paramasamy, Edwin Oei, Jacob J. Visser
Tuesday, Nov 28 9:30 AM - 10:30 AM CST
Know moreAbstract/Poster presentation
Title: Surveillance breeds conformity: Multicenter, post-market surveillance of a multi-finding AI algorithm for the interpretation of chest radiographs
Authors: G. Dasegowda, K. J. Dreyer, S. R. Digumarthy, M. K. Kalra, R. Fahimi, P. Kaviani, E. Garza Frias, L. Karout, B. C. Bizzo, P. Warier, P. Putha, S. Mathur, R. Agrawal
Wednesday, Nov 29 12:15 PM - 12:45 PM CST
Know moreProducts
Please check with our U.S. team to find out about our FDA-cleared portfolio.
AI Powered Reporting & Seamless Collaboration with app.qure.ai
“For conditions such as intracranial hemorrhage, time is of the essence and those precious minutes can be life-changing for our patients. We have done extensive validation of the Qure.ai qER solution and are excited to continue to partner with Qure.ai and improve care for our patients.”
Benjamin W. Strong
MD and Chief Medical Officer
vRad
"A multicenter publication on missed and mislabeled chest radiography findings including pneumothoraces and pleural effusions reported up to 96% sensitivity and 100% specificity for the qXR algorithm."
Dr Subba Digumarthy, MD
Attending Radiologist, Thoracic Imaging, Massachusetts General Hospital
Associate Professor, Harvard Medical School
“AI offers a transformative advantage to Frimley Health NHS Foundation Trust, enabling efficient triage of normal chest X-rays and empowering radiologists to focus on complex cases. By optimising efficiency, Qure’s qXR Chest X-ray solution contributes to better patient outcomes and addresses the critical need for innovative AI solutions in the radiology department.”
Dr Amrita Kumar
Consultant Radiologist and AI Clinical Lead
Frimley Health NHS Foundation Trust
“As an Emergency Medicine Physician, I have 4 to 5 patients undergoing various imaging studies at any time. The AI's ability to rapidly triage pneumothorax dramatically improves my speed and efficiency by alerting me to critical pathology far before a radiologist, or I personally have time to review the film.”
Neil Roy
MD, MBA, FACEP, CPE; Chief Medical Officer
Shady Grove Medical Center
“The collaboration between Qure.ai and Nuance helps make cutting-edge imaging AI easily integrated and accessible to different stakeholders in the US healthcare system. We’re excited to work together to bring scalable diagnostics solutions for providers and patients across the country.”
Roland Dias
Vice President and General Manager
Nuance Precision Imaging Network
“Qure.ai’s technology makes it possible to systematically measure brain hemorrhages precisely and rapidly in patients with stroke or trauma. Fully automated quantification could soon become the standard of care.”
Dr Johan Wasselius
Interventional Neuroradiologist
Skåne University Hospital and Lund University, Sweden
"We are excited to partner with Qure.ai and expand the reach of MammoScreen across the globe. Qure.ai’s extensive distribution network will enable us to deliver our innovative mammography solution to healthcare providers worldwide, enabling early detection of breast cancer and improved patient outcomes”.
Matthieu Leclerc-Chalvet
CEO
Therapixel
“For conditions such as intracranial hemorrhage, time is of the essence and those precious minutes can be life-changing for our patients. We have done extensive validation of the Qure.ai qER solution and are excited to continue to partner with Qure.ai and improve care for our patients.”
Benjamin W. Strong
MD and Chief Medical Officer
vRad
"A multicenter publication on missed and mislabeled chest radiography findings including pneumothoraces and pleural effusions reported up to 96% sensitivity and 100% specificity for the qXR algorithm."
Dr Subba Digumarthy, MD
Attending Radiologist, Thoracic Imaging, Massachusetts General Hospital
Associate Professor, Harvard Medical School
“AI offers a transformative advantage to Frimley Health NHS Foundation Trust, enabling efficient triage of normal chest X-rays and empowering radiologists to focus on complex cases. By optimising efficiency, Qure’s qXR Chest X-ray solution contributes to better patient outcomes and addresses the critical need for innovative AI solutions in the radiology department.”
Dr Amrita Kumar
Consultant Radiologist and AI Clinical Lead
Frimley Health NHS Foundation Trust
“As an Emergency Medicine Physician, I have 4 to 5 patients undergoing various imaging studies at any time. The AI's ability to rapidly triage pneumothorax dramatically improves my speed and efficiency by alerting me to critical pathology far before a radiologist, or I personally have time to review the film.”
Neil Roy
MD, MBA, FACEP, CPE; Chief Medical Officer
Shady Grove Medical Center
“The collaboration between Qure.ai and Nuance helps make cutting-edge imaging AI easily integrated and accessible to different stakeholders in the US healthcare system. We’re excited to work together to bring scalable diagnostics solutions for providers and patients across the country.”
Roland Dias
Vice President and General Manager
Nuance Precision Imaging Network
“Qure.ai’s technology makes it possible to systematically measure brain hemorrhages precisely and rapidly in patients with stroke or trauma. Fully automated quantification could soon become the standard of care.”
Dr Johan Wasselius
Interventional Neuroradiologist
Skåne University Hospital and Lund University, Sweden
"We are excited to partner with Qure.ai and expand the reach of MammoScreen across the globe. Qure.ai’s extensive distribution network will enable us to deliver our innovative mammography solution to healthcare providers worldwide, enabling early detection of breast cancer and improved patient outcomes”.
Matthieu Leclerc-Chalvet
CEO
Therapixel
“For conditions such as intracranial hemorrhage, time is of the essence and those precious minutes can be life-changing for our patients. We have done extensive validation of the Qure.ai qER solution and are excited to continue to partner with Qure.ai and improve care for our patients.”
Benjamin W. Strong
MD and Chief Medical Officer
vRad
"A multicenter publication on missed and mislabeled chest radiography findings including pneumothoraces and pleural effusions reported up to 96% sensitivity and 100% specificity for the qXR algorithm."
Dr Subba Digumarthy, MD
Attending Radiologist, Thoracic Imaging, Massachusetts General Hospital
Associate Professor, Harvard Medical School
“AI offers a transformative advantage to Frimley Health NHS Foundation Trust, enabling efficient triage of normal chest X-rays and empowering radiologists to focus on complex cases. By optimising efficiency, Qure’s qXR Chest X-ray solution contributes to better patient outcomes and addresses the critical need for innovative AI solutions in the radiology department.”
Dr Amrita Kumar
Consultant Radiologist and AI Clinical Lead
Frimley Health NHS Foundation Trust
“As an Emergency Medicine Physician, I have 4 to 5 patients undergoing various imaging studies at any time. The AI's ability to rapidly triage pneumothorax dramatically improves my speed and efficiency by alerting me to critical pathology far before a radiologist, or I personally have time to review the film.”
Neil Roy
MD, MBA, FACEP, CPE; Chief Medical Officer
Shady Grove Medical Center
“The collaboration between Qure.ai and Nuance helps make cutting-edge imaging AI easily integrated and accessible to different stakeholders in the US healthcare system. We’re excited to work together to bring scalable diagnostics solutions for providers and patients across the country.”
Roland Dias
Vice President and General Manager
Nuance Precision Imaging Network
“Qure.ai’s technology makes it possible to systematically measure brain hemorrhages precisely and rapidly in patients with stroke or trauma. Fully automated quantification could soon become the standard of care.”
Dr Johan Wasselius
Interventional Neuroradiologist
Skåne University Hospital and Lund University, Sweden
"We are excited to partner with Qure.ai and expand the reach of MammoScreen across the globe. Qure.ai’s extensive distribution network will enable us to deliver our innovative mammography solution to healthcare providers worldwide, enabling early detection of breast cancer and improved patient outcomes”.
Matthieu Leclerc-Chalvet
CEO
Therapixel
“For conditions such as intracranial hemorrhage, time is of the essence and those precious minutes can be life-changing for our patients. We have done extensive validation of the Qure.ai qER solution and are excited to continue to partner with Qure.ai and improve care for our patients.”
Benjamin W. Strong
MD and Chief Medical Officer
vRad
"A multicenter publication on missed and mislabeled chest radiography findings including pneumothoraces and pleural effusions reported up to 96% sensitivity and 100% specificity for the qXR algorithm."
Dr Subba Digumarthy, MD
Attending Radiologist, Thoracic Imaging, Massachusetts General Hospital
Associate Professor, Harvard Medical School
“AI offers a transformative advantage to Frimley Health NHS Foundation Trust, enabling efficient triage of normal chest X-rays and empowering radiologists to focus on complex cases. By optimising efficiency, Qure’s qXR Chest X-ray solution contributes to better patient outcomes and addresses the critical need for innovative AI solutions in the radiology department.”
Dr Amrita Kumar
Consultant Radiologist and AI Clinical Lead
Frimley Health NHS Foundation Trust
“As an Emergency Medicine Physician, I have 4 to 5 patients undergoing various imaging studies at any time. The AI's ability to rapidly triage pneumothorax dramatically improves my speed and efficiency by alerting me to critical pathology far before a radiologist, or I personally have time to review the film.”
Neil Roy
MD, MBA, FACEP, CPE; Chief Medical Officer
Shady Grove Medical Center
“The collaboration between Qure.ai and Nuance helps make cutting-edge imaging AI easily integrated and accessible to different stakeholders in the US healthcare system. We’re excited to work together to bring scalable diagnostics solutions for providers and patients across the country.”
Roland Dias
Vice President and General Manager
Nuance Precision Imaging Network
“Qure.ai’s technology makes it possible to systematically measure brain hemorrhages precisely and rapidly in patients with stroke or trauma. Fully automated quantification could soon become the standard of care.”
Dr Johan Wasselius
Interventional Neuroradiologist
Skåne University Hospital and Lund University, Sweden
"We are excited to partner with Qure.ai and expand the reach of MammoScreen across the globe. Qure.ai’s extensive distribution network will enable us to deliver our innovative mammography solution to healthcare providers worldwide, enabling early detection of breast cancer and improved patient outcomes”.
Matthieu Leclerc-Chalvet
CEO
Therapixel
“For conditions such as intracranial hemorrhage, time is of the essence and those precious minutes can be life-changing for our patients. We have done extensive validation of the Qure.ai qER solution and are excited to continue to partner with Qure.ai and improve care for our patients.”
Benjamin W. Strong
MD and Chief Medical Officer
vRad
"A multicenter publication on missed and mislabeled chest radiography findings including pneumothoraces and pleural effusions reported up to 96% sensitivity and 100% specificity for the qXR algorithm."
Dr Subba Digumarthy, MD
Attending Radiologist, Thoracic Imaging, Massachusetts General Hospital
Associate Professor, Harvard Medical School
“AI offers a transformative advantage to Frimley Health NHS Foundation Trust, enabling efficient triage of normal chest X-rays and empowering radiologists to focus on complex cases. By optimising efficiency, Qure’s qXR Chest X-ray solution contributes to better patient outcomes and addresses the critical need for innovative AI solutions in the radiology department.”
Dr Amrita Kumar
Consultant Radiologist and AI Clinical Lead
Frimley Health NHS Foundation Trust
“As an Emergency Medicine Physician, I have 4 to 5 patients undergoing various imaging studies at any time. The AI's ability to rapidly triage pneumothorax dramatically improves my speed and efficiency by alerting me to critical pathology far before a radiologist, or I personally have time to review the film.”
Neil Roy
MD, MBA, FACEP, CPE; Chief Medical Officer
Shady Grove Medical Center
“The collaboration between Qure.ai and Nuance helps make cutting-edge imaging AI easily integrated and accessible to different stakeholders in the US healthcare system. We’re excited to work together to bring scalable diagnostics solutions for providers and patients across the country.”
Roland Dias
Vice President and General Manager
Nuance Precision Imaging Network
“Qure.ai’s technology makes it possible to systematically measure brain hemorrhages precisely and rapidly in patients with stroke or trauma. Fully automated quantification could soon become the standard of care.”
Dr Johan Wasselius
Interventional Neuroradiologist
Skåne University Hospital and Lund University, Sweden
"We are excited to partner with Qure.ai and expand the reach of MammoScreen across the globe. Qure.ai’s extensive distribution network will enable us to deliver our innovative mammography solution to healthcare providers worldwide, enabling early detection of breast cancer and improved patient outcomes”.
Matthieu Leclerc-Chalvet
CEO
Therapixel
“For conditions such as intracranial hemorrhage, time is of the essence and those precious minutes can be life-changing for our patients. We have done extensive validation of the Qure.ai qER solution and are excited to continue to partner with Qure.ai and improve care for our patients.”
Benjamin W. Strong
MD and Chief Medical Officer
vRad
"A multicenter publication on missed and mislabeled chest radiography findings including pneumothoraces and pleural effusions reported up to 96% sensitivity and 100% specificity for the qXR algorithm."
Dr Subba Digumarthy, MD
Attending Radiologist, Thoracic Imaging, Massachusetts General Hospital
Associate Professor, Harvard Medical School
“AI offers a transformative advantage to Frimley Health NHS Foundation Trust, enabling efficient triage of normal chest X-rays and empowering radiologists to focus on complex cases. By optimising efficiency, Qure’s qXR Chest X-ray solution contributes to better patient outcomes and addresses the critical need for innovative AI solutions in the radiology department.”
Dr Amrita Kumar
Consultant Radiologist and AI Clinical Lead
Frimley Health NHS Foundation Trust
“As an Emergency Medicine Physician, I have 4 to 5 patients undergoing various imaging studies at any time. The AI's ability to rapidly triage pneumothorax dramatically improves my speed and efficiency by alerting me to critical pathology far before a radiologist, or I personally have time to review the film.”
Neil Roy
MD, MBA, FACEP, CPE; Chief Medical Officer
Shady Grove Medical Center
“The collaboration between Qure.ai and Nuance helps make cutting-edge imaging AI easily integrated and accessible to different stakeholders in the US healthcare system. We’re excited to work together to bring scalable diagnostics solutions for providers and patients across the country.”
Roland Dias
Vice President and General Manager
Nuance Precision Imaging Network
“Qure.ai’s technology makes it possible to systematically measure brain hemorrhages precisely and rapidly in patients with stroke or trauma. Fully automated quantification could soon become the standard of care.”
Dr Johan Wasselius
Interventional Neuroradiologist
Skåne University Hospital and Lund University, Sweden
"We are excited to partner with Qure.ai and expand the reach of MammoScreen across the globe. Qure.ai’s extensive distribution network will enable us to deliver our innovative mammography solution to healthcare providers worldwide, enabling early detection of breast cancer and improved patient outcomes”.
Matthieu Leclerc-Chalvet
CEO
Therapixel
“For conditions such as intracranial hemorrhage, time is of the essence and those precious minutes can be life-changing for our patients. We have done extensive validation of the Qure.ai qER solution and are excited to continue to partner with Qure.ai and improve care for our patients.”
Benjamin W. Strong
MD and Chief Medical Officer
vRad
"A multicenter publication on missed and mislabeled chest radiography findings including pneumothoraces and pleural effusions reported up to 96% sensitivity and 100% specificity for the qXR algorithm."
Dr Subba Digumarthy, MD
Attending Radiologist, Thoracic Imaging, Massachusetts General Hospital
Associate Professor, Harvard Medical School
“AI offers a transformative advantage to Frimley Health NHS Foundation Trust, enabling efficient triage of normal chest X-rays and empowering radiologists to focus on complex cases. By optimising efficiency, Qure’s qXR Chest X-ray solution contributes to better patient outcomes and addresses the critical need for innovative AI solutions in the radiology department.”
Dr Amrita Kumar
Consultant Radiologist and AI Clinical Lead
Frimley Health NHS Foundation Trust
“As an Emergency Medicine Physician, I have 4 to 5 patients undergoing various imaging studies at any time. The AI's ability to rapidly triage pneumothorax dramatically improves my speed and efficiency by alerting me to critical pathology far before a radiologist, or I personally have time to review the film.”
Neil Roy
MD, MBA, FACEP, CPE; Chief Medical Officer
Shady Grove Medical Center
“The collaboration between Qure.ai and Nuance helps make cutting-edge imaging AI easily integrated and accessible to different stakeholders in the US healthcare system. We’re excited to work together to bring scalable diagnostics solutions for providers and patients across the country.”
Roland Dias
Vice President and General Manager
Nuance Precision Imaging Network
“Qure.ai’s technology makes it possible to systematically measure brain hemorrhages precisely and rapidly in patients with stroke or trauma. Fully automated quantification could soon become the standard of care.”
Dr Johan Wasselius
Interventional Neuroradiologist
Skåne University Hospital and Lund University, Sweden
"We are excited to partner with Qure.ai and expand the reach of MammoScreen across the globe. Qure.ai’s extensive distribution network will enable us to deliver our innovative mammography solution to healthcare providers worldwide, enabling early detection of breast cancer and improved patient outcomes”.
Matthieu Leclerc-Chalvet
CEO
Therapixel